S. Marin
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
-
- Breast Cancer Treatment Studies 10
- Cancer Genomics and Diagnostics 4
-
- Breast Lesions and Carcinomas 6
- Co-authors
- E. M. ALHAVA (14 shared papers)Kari Juhani Syrjänen (12 shared papers)Matti J. Eskelinen (7 shared papers)P. Lipponen (8 shared papers)Sirpa H. Aaltomaa (11 shared papers)Veli‐Matti Kosma (6 shared papers)Pertti Lipponen (9 shared papers)V-M Kosma (1 shared paper)
- Journals
- Scandinavian Journal of Gastroenterology (3 papers)International Journal of Cancer (2 papers)Journal of Cancer Research and Clinical Oncology (1 paper)Journal of Clinical Oncology (1 paper)The American Journal of Surgery (1 paper)
- Partner nations
- Finland
In The Last Decade
S. Marin
20 papers receiving 657 citations
Peers
Comparison fields: 5 of 57
- Oncology 332
- Cancer Research 180
- Otorhinolaryngology 36
- Immunology 117
- Pathology and Forensic Medicine 58
Countries citing papers authored by S. Marin
This map shows the geographic impact of S. Marin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Marin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Marin more than expected).
Fields of papers citing papers by S. Marin
This network shows the impact of papers produced by S. Marin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Marin. The network helps show where S. Marin may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Marin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 245 | |
| 2 | 1996 | 82 | |
| 3 | 1997 | 65 | |
| 4 | 1992 | 44 | |
| 5 | 1991 | 42 | |
| 6 | 1992 | 27 | |
| 7 | Retroperitoneal fibrosis with antineutrophil cytoplasmic antibodies. | 1996 | 26 |
| 8 | 1991 | 25 | |
| 9 | 1990 | 20 | |
| 10 | 1992 | 18 | |
| 11 | 1991 | 18 | |
| 12 | Nuclear morphometry and DNA flow cytometry as prognostic factors in female breast cancer. | 1992 | 15 |
| 13 | The significance of nuclear morphometric variables as prognostic predictors in breast cancer. | 1992 | 12 |
| 14 | Sex steroid receptors, S-phase fraction and DNA ploidy as determinants of the risk of relapse and death of female breast cancer. | 1992 | 9 |
| 15 | 2008 | 7 | |
| 16 | 1993 | 7 | |
| 17 | Prediction of outcome after first recurrence of breast cancer. | 1992 | 6 |
| 18 | 1997 | 6 | |
| 19 | 2009 | 5 | |
| 20 | Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma. | 1992 | 2 |
About S. Marin
S. Marin is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 20 papers that have together received 681 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (6 papers), Cancer Genomics and Diagnostics (4 papers), HER2/EGFR in Cancer Research (4 papers), Estrogen and related hormone effects (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (332 citations), Cancer Research (180 citations), Otorhinolaryngology (36 citations), Immunology (117 citations) and Pathology and Forensic Medicine (58 citations). S. Marin has collaborated with scholars based in Finland. Frequent co-authors include E. M. ALHAVA, Kari Juhani Syrjänen, Matti J. Eskelinen, P. Lipponen, Sirpa H. Aaltomaa, Veli‐Matti Kosma, Pertti Lipponen, V-M Kosma, Johanna Kuusisto and Matti Eskelinen. Their work appears in journals such as Scandinavian Journal of Gastroenterology, International Journal of Cancer, Journal of Cancer Research and Clinical Oncology, Journal of Clinical Oncology and The American Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.